About Us
The Power Of The Worlds First Precision Medicine Network
"With proprietary technology, we empower everyday people to make informed health choices. Genetic insights, AI, and digital therapeutics aren't just buzzwords, they're tools we leverage to connect people with the most impactful solutions for their health today. And we're driving progress for entire populations, too." -Karen Ferrell, CEO
Our Team
Karen Ferrell
Eran Feldhay
Eran Feldhay
Karen is the co-founder and CEO of My Genomic Insights. She consistently delivered strong financial results for publicly traded health plans and private equity-backed healthcare companies.
Karen served as CEO of Genomic Life, Executive Chairman and CEO of Advantum Health, Glenridge Healthcare Solutions, and Apollo Health Streetwhere she l
Karen is the co-founder and CEO of My Genomic Insights. She consistently delivered strong financial results for publicly traded health plans and private equity-backed healthcare companies.
Karen served as CEO of Genomic Life, Executive Chairman and CEO of Advantum Health, Glenridge Healthcare Solutions, and Apollo Health Streetwhere she led two successful exits.
Karen served as Senior Vice President of Provider Contracting &Medical Management for CIGNA Healthcare, responsible for $32 billion in medical costs, Executive Director at Scripps Health and President of Aetna Health Plans of Florida.
Karen received an MBA from the Graziadio Business School at Pepperdine University.
Eran Feldhay
Eran Feldhay
Eran Feldhay
Eran serves as co-founder, CEO and Chief Clinical Officer to My Gene Insights where he leads strategy for Clinical AI development. Eran is founder and CEO of OpenDNA where he developed CardioRisk+ precision medicine software.
Eran served as VP of Marketing and Product Management at Medcon, GM of McKesson Israel, and VP Cardiology for McK
Eran serves as co-founder, CEO and Chief Clinical Officer to My Gene Insights where he leads strategy for Clinical AI development. Eran is founder and CEO of OpenDNA where he developed CardioRisk+ precision medicine software.
Eran served as VP of Marketing and Product Management at Medcon, GM of McKesson Israel, and VP Cardiology for McKesson Imaging Group. He served as CEO of Trendlines Medical, CEO for ApiFix, a spine medical device company and the CMO of Analysis acquired by Philips (NYSE:PHG).
Eran Holds an M.D. and B.Sc. from Tel Aviv University as well as an MBA from Ben-Gurion University of the Negev.
Tony Vance
Eran Feldhay
Nir Gamliel
Tony is a co-founder and our Chief Commercial Officer. He has over 20 years experience in healthcare working for both small startups and Fortune 500 companies including Aetna CVS Health, Optum and United Health Group.
Tony helped found, launch and sell one of the first A.I. business reconnaissance platforms in the world, 100 Joules.
A gr
Tony is a co-founder and our Chief Commercial Officer. He has over 20 years experience in healthcare working for both small startups and Fortune 500 companies including Aetna CVS Health, Optum and United Health Group.
Tony helped found, launch and sell one of the first A.I. business reconnaissance platforms in the world, 100 Joules.
A graduate of Stetson University, where he majored in Communications and International Business, Tony has an MA in Corporate Communications from Duquesne University, and an MBA from Duke University.
Nir Gamliel
Nir Gamliel
Nir Gamliel
Nir is the Chief product and business officer for My Gene Insights. Nir has decades of entrepreneurship and experience in life-sciences and startup companies. During his career Nir initiated and executed multiple M&A and commercialization deals..
Nir was the CEO of PharBeyond where he the managed the sale of Inspiro Medical to OPKO. He s
Nir is the Chief product and business officer for My Gene Insights. Nir has decades of entrepreneurship and experience in life-sciences and startup companies. During his career Nir initiated and executed multiple M&A and commercialization deals..
Nir was the CEO of PharBeyond where he the managed the sale of Inspiro Medical to OPKO. He served as VP BD at BioLineRx where he signed a large commercialization deal with IKARIA for $282M, VP Sales at Compugen USA, Inc. and franchise manager at J&J.
Nir has a B.Sc. in Biology from Bar Ilan University
Erez Ornan
Nir Gamliel
Erez Ornan
Erez is the CTO of My Gene Insights. He has over 25 years experience in management and software development for devices in fields related to biology. Erez has vast experience developing Firmware, Software, Cloud based web and Ai machine and deep learning applications.
Erez was director of software development group at Bio-Rad before joi
Erez is the CTO of My Gene Insights. He has over 25 years experience in management and software development for devices in fields related to biology. Erez has vast experience developing Firmware, Software, Cloud based web and Ai machine and deep learning applications.
Erez was director of software development group at Bio-Rad before joining OpenDNA.
Has a bachelor's degree in computer science and management from Tel Aviv University, and a master's degree in philosophy from Haifa University.